Who is sponsoring NCT04652375?

NCT04652375 is sponsored by Yale University.

What drugs are being tested in NCT04652375?

Interventions in NCT04652375: Albumin Solution, Lactated Ringer's Solution.

What condition does NCT04652375 study?

NCT04652375 studies Coronary Artery Bypass Graft Surgery, Aortic Valve Replacement.

Is NCT04652375 still recruiting?

NCT04652375 is currently completed. Last updated 23 September 2024.

Last reviewed 2024-09-23 · How we verify

NCT04652375

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures

Completed NA Last updated 23 September 2024

What this trial tests

NA trial testing Albumin Solution in Coronary Artery Bypass Graft Surgery in 131 participants. Completed in 26 July 2022.

Timeline

1 July 2021

Primary endpoint
26 July 2022

26 July 2022

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	131
Start date	1 July 2021
Primary completion	26 July 2022
Estimated completion	26 July 2022
Sites	1 location across United States

Drugs / interventions tested

Albumin Solution
Lactated Ringer's Solution — full drug profile →

Conditions studied

Coronary Artery Bypass Graft Surgery — all drugs for Coronary Artery Bypass Graft Surgery →
Aortic Valve Replacement — all drugs for Aortic Valve Replacement →

Sponsor

Yale University

Who can join

18 and older, any sex, with Coronary Artery Bypass Graft Surgery or Aortic Valve Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized, double-blinded study to compare the use of albumin versus lactated Ringer's solution in patients undergoing coronary artery bypass graft surgery and in patients undergoing aortic valve replacement surgery and evaluate the incidence of acute kidney injury as a primary outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coronary Artery Bypass Graft Surgery

Currently open trials in the same condition.

NCT07035756 — Development of an Arterial Pressure Monitoring Set Fixation Apparatus · NA · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04652375 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 23 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04652375.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing